These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2960051)

  • 1. 15-Deoxyspergualin (a new guanidine-like drug) blocks T lymphocyte proliferation.
    Falk W; Ulrichs K; Müller-Ruchholtz W
    Transplant Proc; 1987 Oct; 19(5):4239-40. PubMed ID: 2960051
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro.
    Kerr PG; Atkins RC
    Transplantation; 1989 Dec; 48(6):1048-52. PubMed ID: 2531949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Deoxyspergualin, a novel immunosuppressive drug: studies of the mechanism of action.
    Tepper MA; Nadler S; Mazzucco C; Singh C; Kelley SL
    Ann N Y Acad Sci; 1993 Jun; 685():136-47. PubMed ID: 8363218
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro immunosuppressive properties of spergualins to murine T cell response.
    Fujii H; Takada T; Nemoto K; Abe F; Fujii A; Takeuchi T
    J Antibiot (Tokyo); 1989 May; 42(5):788-94. PubMed ID: 2524464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of deoxyspergualin on human lymphocyte proliferation in vitro.
    Kerr PG; Atkins RC
    Transplant Proc; 1989 Oct; 21(5):3765-6. PubMed ID: 2815272
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
    Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of 15-deoxyspergualin on rejection detected by 31P nuclear magnetic resonance spectroscopy and in vivo mechanisms of action in rat heart transplantation.
    Suzuki S; Kanashiro M; Watanabe H; Sakakibara I; Amemiya H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1094-5. PubMed ID: 2523115
    [No Abstract]   [Full Text] [Related]  

  • 8. 15-Deoxyspergualin inhibits nitric oxide production in the BB/W rat: mechanism for inhibition of islet cell dysfunction in diabetes and transplantation.
    Stevens RB; Lokeh A; Ansite JD; Rossini TJ; Sutherland DE; Mills CD
    Transplant Proc; 1994 Dec; 26(6):3370. PubMed ID: 7527968
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with 15-deoxyspergualin induces temporal suppression of hemopoiesis and changes thymocyte populations in mice.
    Mochida-Nishimura K; Tokunaga T
    Immunopharmacology; 1996 Oct; 35(1):65-70. PubMed ID: 8913796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies to CTLA-4 enhance T cell proliferation.
    Matsui T; Nishioka K; Kato T; Yamamoto K
    J Rheumatol; 2001 Jan; 28(1):220-1. PubMed ID: 11196536
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 13. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of immunosuppressives on gamma-interferon production, lymphocyte proliferation, and cytotoxic function of activated T lymphocytes.
    Bishop GA; Hall BM
    Transplant Proc; 1987 Apr; 19(2):2866-8. PubMed ID: 3105124
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
    Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
    Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of IL-2 and IL-4 with the effects of deoxyspergualin.
    Kerr PG; Atkins RC
    Transplant Proc; 1990 Oct; 22(5):2121-2. PubMed ID: 2219316
    [No Abstract]   [Full Text] [Related]  

  • 17. Deoxyspergualin. Mechanism of action studies of a novel immunosuppressive drug.
    Tepper MA
    Ann N Y Acad Sci; 1993 Nov; 696():123-32. PubMed ID: 8109823
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppressor cells induced by donor-specific transfusion and deoxyspergualin in cardiac xenografts from hamsters to rats.
    Valdivia LA; Wonden W; Gotoh M; Tono T; Nakano Y; Okamura J; Mori T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):203-4. PubMed ID: 1824975
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
    Lin Y; Goebels J; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of immunosuppressive mechanism of deoxymethylspergualin in vitro].
    Uemura T
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1301-7. PubMed ID: 8355445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.